Replacing inpatient care by outpatient care in the treatment of deep venous thrombosis -: An economic evaluation

被引:95
|
作者
van den Belt, AGM
Bossuyt, PMM
Prins, MH
Gallus, AS
Büller, HR
机构
[1] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol & Biostat, NL-1100 DE Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Ctr Haemostas Thrombos Atheroscler & Inflamm Res, NL-1100 DE Amsterdam, Netherlands
[3] Flinders Med Ctr, Adelaide, SA, Australia
关键词
D O I
10.1055/s-0037-1614975
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Two clinical trials in patients with acute deep venous thrombosis have indicated that the outpatient management with fixed-dose, subcutaneous low-molecular-weight heparin is at least as effective and safe as inpatient treatment with unfractionated intravenous heparin with respect to recurrent venous thromboembolism and major bleeding. We performed an economic evaluation alongside one of these trials to assess the cost consequences of the outpatient management strategy. Data were collected through case record forms, complemented by a prospective questionnaire in 78 consecutive patients, interviews with health care providers, and hospital data bases. Our study demonstrated that seventy-five percent of patients allocated to low-molecular-weight heparin received treatment either entirely al home or after a brief hospital stay. Fifteen percent of these patients required professional domiciliary care. Within-centre comparisons of resource utilisation in terms of natural units showed that outpatient management with low-molecular-weight heparin reduced the average number of hospital days in the initial treatment period in nine centres by 59 percent (95% CI: 43 to 71 percent) accompanied by a limited increase in outpatient and professional domiciliary care. The average reduction in hospital days at the end of follow up was 40 percent (95% CI: 25 to 54 percent). A cost-minimisation analysis, focusing on resource utilisation directly related to the treatment of deep venous thrombosis and associated costs in one centre demonstrated a cost reduction of 64 percent (95% CI: 56 to 72 percent) with the outpatient management with low-molecular-weight heparin. These data suggest that outpatient management of patients with proximal venous thrombosis using low-molecular-weight heparin reduces resource utilisation and total treatment cost. Implementation should be preceded by a cautious evaluation of a potential cost shifting and organisational prerequisites.
引用
收藏
页码:259 / 263
页数:5
相关论文
共 50 条
  • [1] Deep venous thrombosis:: a new task for primary health care -: A randomised economic study of outpatient and inpatient treatment
    Bäckman, K
    Carlsson, P
    Kentson, M
    Hansen, S
    Engquist, L
    Hallert, C
    [J]. SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE, 2004, 22 (01) : 44 - 49
  • [2] Inpatient vs outpatient treatment of deep venous thrombosis
    Wagner, T
    [J]. INTERNIST, 1996, 37 (09): : 943 - 943
  • [3] Outpatient treatment of deep venous thrombosis: A clinical care pathway managed by the emergency department
    Vinson, DR
    Berman, DA
    [J]. ANNALS OF EMERGENCY MEDICINE, 2001, 37 (03) : 251 - 258
  • [4] Outpatient treatment of deep venous thrombosis
    Yusen, RD
    Haraden, BM
    Gage, BF
    Rubin, BG
    Botney, MD
    [J]. CHEST, 1999, 116 (05) : 1493 - 1493
  • [5] Outpatient management of deep venous thrombosis: 2 models of integrated care
    Vinson, David R.
    Berman, David A.
    Patel, Pankaj B.
    Hickey, Dominic O.
    [J]. AMERICAN JOURNAL OF MANAGED CARE, 2006, 12 (07): : 405 - 410
  • [6] Treatment of deep venous thrombosis in an outpatient setting
    Stockelberg, D
    Jonsson, T
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 48 - 48
  • [7] Outpatient treatment in proximal deep venous thrombosis
    Schwarz, T
    Schröder, HE
    Schellong, SM
    [J]. VASA-JOURNAL OF VASCULAR DISEASES, 2000, 29 (01): : 11 - 15
  • [8] Shifting from inpatient to outpatient treatment of deep vein thrombosis in a tertiary care center: A cost-minimization analysis
    Boucher, M
    Rodger, M
    Johnson, JA
    Tierney, M
    [J]. PHARMACOTHERAPY, 2003, 23 (03): : 301 - 309
  • [9] Outpatient care before inpatient care
    Lisiak, B
    [J]. GESUNDHEITSWESEN, 2003, 65 (8-9) : 536 - 536
  • [10] Uncomplicated outpatient deep venous thrombosis management with a novel care pathway: Is it ready for prime time?
    Godoy, Alejandro
    Carlin, Stephanie
    Douketis, James D.
    [J]. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2024, 122 : 40 - 41